Tsunemasa Irie

Title: Tsunemasa Irie: Innovator in Neurotrophic Peptides

Introduction

Tsunemasa Irie is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of neurotrophic peptides, with a focus on developing treatments for neuro-degenerative disorders and dementia. His innovative work has led to the filing of two patents, showcasing his dedication to advancing medical science.

Latest Patents

One of Tsunemasa Irie's latest patents is titled "Equipment for Intracerebral Administration of Preparations." This invention provides human- or rat-derived neurotrophic peptides and derivatives, along with precursor peptides and genes encoding the same. It also includes transformants containing recombinant expression vectors bearing the genes, and compositions that comprise these neurotrophic peptides or derivatives as effective ingredients. The neurotrophic peptides or their derivatives possess neurotrophic activity, making them useful for treating neuro-degenerative disorders and dementia.

Career Highlights

Throughout his career, Tsunemasa Irie has worked with notable companies, including Sumitomo Pharmaceuticals Company Limited and Koken Company, Limited. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of Tsunemasa Irie's coworkers include Toru Hayakawa and Toshiki Yoshimine. Their collaborative efforts have further enhanced the impact of his inventions and research.

Conclusion

Tsunemasa Irie is a distinguished inventor whose work in neurotrophic peptides has the potential to transform the treatment of neuro-degenerative disorders. His patents reflect a commitment to innovation and improving human health.